Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diversity of Chlamydia trachomatis in Trachoma-Hyperendemic Communities Treated With Azithromycin.

American journal of epidemiology - 1 Sept 2018

Chin Stephanie A, Morberg Daniel P, Alemayehu Wondu, Melese Muluken, Lakew Takele, Chen Michael C, Zhou Zhaoxia, Doan Thuy, Cevallos Vicky, Lietman Thomas M, Keenan Jeremy D

Abstract excerpt

Prior studies have theorized that low chlamydial genetic diversity following mass azithromycin treatments for trachoma may create a population bottleneck that prevents the return of infection, but little empirical evidence exists to support this hypothesis. In this study, a single mass azithromycin distribution was administered to 21 communities in the Gurage Zone of Ethiopia in 2003. All children aged 1-5 years...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Azithromycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bacterial Outer Membrane Proteins

Share to Chlamydia trachomatis

Share to Genetic Variation

Source

Open in PubMed Open full text

Identifiers

PMID: 29617922
DOI: 10.1093/aje/kwy071
PMCID: PMC6118063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diversity of Chlamydia trachomatis in Trachoma-Hyperendemic Communities Treated With Azithromycin.PMID 29617922Read ↗

Chlamydia trachomatis ompA variants in trachoma: what do they tell us?Semantic proximity Read ↗

Unravelling Chlamydia trachomatis diversity in Amhara, Ethiopia: MLVA-ompA sequencing as a molecular typing tool for trachoma.Semantic proximity Read ↗

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, EthiopiaSemantic proximity Read ↗

Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.Semantic proximity Read ↗

Putative azithromycin resistance mutations in Chlamydia trachomatis are globally distributed but arose before azithromycin was discovered.Semantic proximity Read ↗

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.Semantic proximity Read ↗

Unravelling <i>Chlamydia trachomatis</i> Diversity in Amhara, Ethiopia: MLVA- <i>ompA</i> Sequencing as a Molecular Typing Tool for TrachomaSemantic proximity Read ↗

Putative azithromycin-resistance mutations in <i>Chlamydia trachomatis</i> are globally distributed but arose before azithromycin was discoveredSemantic proximity Read ↗

Clinical Activity and Polymerase Chain Reaction Evidence of Chlamydial Infection after Repeated Mass Antibiotic Treatments for TrachomaSemantic proximity Read ↗

Evidence for Clonal Expansion After Antibiotic Selection Pressure: Pneumococcal Multilocus Sequence Types Before and After Mass Azithromycin TreatmentsSemantic proximity Read ↗

Genomics of Ocular <i>Chlamydia trachomatis</i> after 5 years of SAFE interventions for trachoma in Amhara, EthiopiaSemantic proximity Read ↗

Genetic diversity of Chlamydia trachomatis and the prevalence of trachoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.